MPLT — MAPLIGHT THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 114 SEC-registered investment managers reported holding MPLT (MAPLIGHT THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $958.95M across 28.18M shares. That is +7.1% by share count (+1.67M shares) versus the previous quarter, while reported value moved +79.0%. Ownership is concentrated: the five largest holders account for 48.8% of reported value and the top ten for 66.3%.
Compared with the prior quarter, 42 opened new positions, 23 added to existing stakes, 30 trimmed, 13 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of MAPLIGHT THERAPEUTICS INC (MPLT) include Novo Holdings A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., ranked by reported 13F value among the 147 institutional holders on this page.
MPLT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 59 | 11.42M | $116.40M | +42.1% |
| Q2 2026 | 114 | 28.18M | $958.95M | +7.1% |
| Q1 2026 | 85 | 25.16M | $509.26M | +8.4% |
| Q4 2025 | 77 | 23.43M | $411.44M | — |
Over the 4 quarters shown, institutional share counts decreased 51% in aggregate (Q4 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (+8.4%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.30M | $23.44M | 15.84% | Add | |
| 1.71M | $17.45M | 0.00% | Add | |
| 1.54M | $15.71M | 0.00% | Add | |
| 912.04K | $9.29M | 1.48% | Hold | |
| 612.31K | $6.24M | 0.01% | Add | |
| 611.45K | $6.23M | 2.54% | Hold | |
| 556.37K | $5.67M | 1.07% | Reduce | |
| 440.73K | $4.49M | 0.00% | Add | |
| 415.76K | $4.24M | 0.00% | Hold | |
| 396.08K | $4.04M | 0.00% | Reduce | |
| 313.59K | $3.20M | 0.00% | Reduce | |
| 245.22K | $2.50M | 0.00% | Add | |
| 170.86K | $1.74M | 0.00% | Hold | |
| 140.89K | $1.43M | 0.00% | Add | |
| 120.87K | $1.23M | 0.00% | Add | |
| 116.46K | $1.19M | 0.00% | Reduce | |
| 102.23K | $1.04M | 0.00% | Reduce | |
| 85.81K | $874.43K | 0.00% | Add | |
| 83.74K | $853.00K | 0.00% | Add | |
| 83.27K | $848.56K | 0.00% | Add | |
| 74.48K | $759.00K | 0.01% | New | |
| 60.72K | $618.70K | 0.00% | Add | |
| 59.17K | $602.97K | 0.00% | Add | |
| 58.46K | $595.72K | 0.01% | Add | |
| 30.96K | $315.45K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.69M | $64.76M | 5.03% | New | |
| 3.23M | $56.67M | 7.43% | New | |
| 2.80M | $49.17M | 0.03% | New | |
| 1.94M | $34.03M | 0.01% | New | |
| 1.10M | $19.24M | 0.00% | New | |
| 971.25K | $17.06M | 15.27% | New | |
| 950.01K | $16.69M | 5.25% | New | |
| 912.04K | $16.02M | 5.16% | New | |
| 869.67K | $15.28M | 0.00% | New | |
| 611.45K | $10.74M | 4.15% | New | |
| 550.00K | $9.66M | 0.18% | New | |
| 522.30K | $9.17M | 5.40% | New | |
| 450.00K | $7.90M | 0.24% | New | |
| 389.03K | $6.83M | 0.00% | New | |
| 385.00K | $6.76M | 0.23% | New | |
| 364.70K | $6.41M | 0.04% | New | |
| 327.69K | $5.76M | 0.06% | New | |
| 327.06K | $5.74M | 1.77% | New | |
| 229.48K | $4.03M | 0.00% | New | |
| 207.49K | $3.64M | 0.01% | New | |
| 207.49K | $3.64M | 0.01% | New | |
| 199.23K | $3.50M | 0.70% | New | |
| 190.14K | $3.34M | 0.00% | New | |
| 183.77K | $3.23M | 0.02% | New | |
| 164.53K | $2.89M | 0.61% | New |
New Positions (Q2 2026)
- Paradigm Biocapital Advisors LP 685.85K sh · $24.58M
- Capital World Investors 415.73K sh · $14.90M
- Capital World Investors 415.73K sh · $14.90M
- GEODE CAPITAL MANAGEMENT, LLC 402.05K sh · $14.41M
- Sixth Street Partners Management Company, L.P. 136.82K sh · $4.90M
- Millennium Management 128.84K sh · $4.62M
- MILLENNIUM MANAGEMENT LLC 128.84K sh · $4.62M
- Boxer Capital Management, LLC 75.00K sh · $2.69M
- Trexquant Investment LP 63.79K sh · $2.29M
- HRT FINANCIAL LP 51.98K sh · $1.86M
- Jain Global LLC 45.55K sh · $1.63M
- BRIDGEWAY CAPITAL MANAGEMENT, LLC 35.00K sh · $1.25M
Fully Exited (vs previous quarter)
- Vestal Point Capital, LP sold 420.00K sh · $8.54M
- STATE STREET CORP sold 339.12K sh · $6.89M
- RA CAPITAL MANAGEMENT, L.P. sold 248.29K sh · $5.05M
- Board of Trustees of The Leland Stanford Junior University sold 199.23K sh · $4.05M
- Tetragon Partners GP Ltd sold 112.11K sh · $2.28M
- Janus Henderson Group sold 54.75K sh · $1.11M
- TUDOR INVESTMENT CORP ET AL sold 36.74K sh · $746.92K
- Walleye Capital LLC sold 11.57K sh · $235.26K
- STRS OHIO sold 3.00K sh · $60.99K
- CWM, LLC sold 57 sh · $1.16K
- Root Financial Partners, LLC sold 28 sh · $569
- MAI Capital Management sold 12 sh · $244
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|---|
| Nan Fung Group Holdings Ltd | 2.30M | 971.25K | 971.25K | 971.25K |
| BlackRock Inc | 1.71M | 1.03M | 1.34M | 1.10M |
| Fidelity Management & Research (FMR) | 1.54M | 823.56K | 204.50K | 904 |
| Sanofi | 912.04K | 912.04K | 912.04K | 912.04K |
| Marshall Wace | 612.31K | 5.80K | — | 39.66K |
| Pivotal bioVenture Partners Investment Advisor LLC | 611.45K | 611.45K | 611.45K | 611.45K |
| Blue Owl Capital Holdings LP | 556.37K | 729.93K | 1.01M | 327.06K |
| Geode Capital Management | 440.73K | 402.05K | 481.20K | 389.03K |
| Capital World Investors | 415.76K | 415.73K | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 396.08K | 784.15K | 719.82K | — |
| STATE STREET CORP | 313.59K | — | 339.12K | 229.48K |
| BNP PARIBAS FINANCIAL MARKETS | 245.22K | 70.48K | 37.30K | 3.46K |
| BNP Paribas Asset Management Holding S.A. | 170.86K | 170.86K | 267.75K | 147.93K |
| TD ASSET MANAGEMENT INC | 140.89K | 54.53K | 47.77K | 36.96K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 120.87K | 96.76K | 112.60K | — |
| VANGUARD FIDUCIARY TRUST CO | 116.46K | 123.14K | 131.23K | — |
| UBS Group AG | 102.23K | 122.03K | 236.51K | 18.29K |
| BARCLAYS PLC | 85.81K | 12.97K | 5.79K | 26.41K |
| HRT FINANCIAL LP | 83.74K | 51.98K | — | — |
| Manulife Financial | 83.27K | 7.04K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold MPLT?
As of 2026-Q2, 114 institutional funds reported holding MPLT (MAPLIGHT THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $958.95M.
How many shares of MPLT do institutions own?
13F filers reported 28.18M shares of MPLT, worth $958.95M in aggregate at the end of 2026-Q2.
Is institutional ownership of MPLT rising or falling?
Share counts moved +7.1% versus the prior quarter — accumulation.
Who are the top institutional holders of MPLT?
The largest 13F holders are Novo Holdings A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., Goldman Sachs Group, PRICE T ROWE ASSOCIATES INC /MD/; the top 25 are ranked at the top of this page.
Who are the major shareholders of MAPLIGHT THERAPEUTICS INC?
The major shareholders of MAPLIGHT THERAPEUTICS INC (MPLT) by reported 13F value are Novo Holdings A/S, FCPM III SERVICES B.V., T. Rowe Price Investment Management, Inc., Goldman Sachs Group, PRICE T ROWE ASSOCIATES INC /MD/, among 147 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.